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In the United States, motor vehicle crashes are
the leading cause of death for children aged
8 to 19 years, and the second leading cause
of death for children aged 4 to 7 years.1---3
Virtually all motor vehicle-related pedestrian
injuries are preventable. One way of reducing
childhood motor vehicle injury is to improve
roadway safety.4---7 However, roadway im-
provements require a large up-front invest-
ment, and the chance of a child being severely
injured in any given intersection is relatively
small. Nevertheless, such improvements re-
main in place for decades, producing long-term
benefits on a single investment. Given the high
cost but the long-term benefits, there is un-
certainty surrounding the cost-effectiveness of
roadway improvements.
One roadway improvement program is Safe
Routes to School (SRTS).8---10 SRTS was enacted
under the federal Safe, Accountable, Flexible
and Efficient Transportation Equity (SAFETEA)
Act in 2005 (Pub L No. 109-59). SRTS was
a $612 million dollar program that funded state
departments of transportation to build new
sidewalks and bicycle lanes, improve safety
at crossings (e.g., via traffic calming measures),
upgrade signage, and enhance pedestrian
education.8,12 The intent of SRTS was to
encourage children to walk and bike to school
by making school travel safer, thereby reducing
an important barrier to commuting outside
of a vehicle. Capital improvement projects
were funded at 10 400 schools in the United
States. In 2012, Congress enacted Moving
Ahead for Progress in the 21st Century
(MAP-21; Pub L No. 112-141) to replace the
SAFETEA. As a result, dedicated funding for
SRTS ended, though the program may con-
tinue under discretionary funding at the state
and local level.
Approximately $10 million in the initial
wave of funding went to the New York City
Department of Transportation, which intro-
duced safety improvements at 124 schools
with the highest injury rates.11 SRTS has been
evaluated using a variety of techniques, in-
cluding a difference in difference design and
a Bayesian changepoint analysis.5 SRTS has
been found to produce an 11% increase in
active transport to school (walking or biking)
while simultaneously leading to a 33% to 44%
reduction in school-age injury rates in high-
risk intersections within New York City.5,12,13
Among all users of these intersections, injury
reduction rates were more modest, with about
a 14% decline.5
This analysis assesses the cost-effectiveness
of SRTS in preventing pedestrian injuries among
school-aged children traveling to and from
school (the intent of the program) relative to the
status quo. We examined this subpopulation
because it is the target of the SRTS legislation.
We also examined the cost-effectiveness of
SRTS for all users at all times. This latter analysis
provides the overall societal benefits of the
program, whether intended or not.
METHODS
We set out to determine the cost-effectiveness
of the SRTS program in New York City for both
school-aged children (the target of the legislation)
and adult users of the improved intersections.
When both estimates are summed, we obtain
the actual societal cost of the program. In
New York City, SRTS was targeted toward
the highest-risk intersections, so our research
question focused specifically on intersections
with a history of a high rate of injury. Our
models estimated fluctuation in costs associated
with childhood pedestrian injury and changes
in quality-adjusted life expectancy (QALE) that
occurs when high-risk intersections are modi-
fied. These models, built using TreeAge Pro
2013 (TreeAge software, Williamstown, MA),
are designed to estimate outcomes for the
average school-aged pedestrian over his or
her lifetime or the average incidental adult
SRTS user over his or her lifetime. Thus,
these models present the net present value
of a single year of SRTS intersection use. To
estimate total annual costs, we multiplied these
values by the estimated number of users.
We only included those medical costs asso-
ciated with the initial injury, changes in QALE,
changes in bussing costs, and changes in burial
costs. All outcomes were adjusted to 2013
constant dollars and discounted at a rate of 3%
per year.
The models are designed such that, in the
first year, the intersection user has a very
small risk of injury and a significant chance of
remaining healthy. If the user remains healthy,
Objective. We evaluated the cost-effectiveness of a package of roadway
modifications in New York City funded under the Safe Routes to School (SRTS)
program.
Methods.We used a Markov model to estimate long-term impacts of SRTS on
injury reduction and the associated savings in medical costs, lifelong disability,
and death. Model inputs included societal costs (in 2013 US dollars) and observed
spatiotemporal changes in injury rates associated with New York City’s implemen-
tation of SRTS relative to control intersections. Structural changes to roadways
were assumed to last 50 years before further investment is required. Therefore,
costs were discounted over 50 consecutive cohorts of modified roadway users
under SRTS.
Results. SRTS was associated with an overall net societal benefit of $230
million and 2055 quality-adjusted life years gained in New York City.
Conclusions. SRTS reduces injuries and saves money over the long run. (Am J
Public Health. 2014;104:1294–1299. doi:10.2105/AJPH.2014.301868)
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then we assign no costs other than SRTS capital
costs and, in the child model, changes in
bussing use. If the user is injured, we assign the
user the initial medical costs associated with
an injury and a very small risk of death. If the
user survives, we assume that all future soci-
etal costs will be subsumed by the change in
health-related quality of life (HRQL) score.14
Both the SRTS arm and the arm modeling the
unmodified intersections are identical except
that the SRTS arm contains a reduced risk of
injury, reduced costs associated with active
transport, and upfront costs associated with
SRTS. To estimate the total societal costs, these
lifelong costs (for a given annual cohort of
users) are then multiplied over the projected
useful 50-year time horizon of an intersection
modification and discounted at 3% in a sepa-
rate model. Both models were validated using
a spreadsheet, but we used TreeAge to allow
for sophisticated sensitivity analyses.
Costs
Monetary costs were adjusted to constant
2012 US dollars and are listed in Table 1.15,16
Costs associated with pedestrian injuries were
obtained using the Center for Disease Control
and Prevention’s Web-based Injury Statistics
Query And Reporting System (CDCWISQARS)
and a comprehensive analysis of multiple sour-
ces of 2000 data.17
The average annual cost of transporting a
child to school, $692, was obtained from the
US Department of Education.18 Since the vast
majority of children under SRTS commute on
foot rather than bike,12 we assumed that active
transport carried no costs. Costs associated
with death and memorial preferences were
derived from the 2009 National Funeral Di-
rector’s survey, then inflated using the general
CPI.16 Our estimated cost of death considered
the average cost of burial versus cremation
and their associated frequencies. The total cost
of the SRTS program in New York City was
$10 298 000.
Health-Related Quality of Life
QALE is the product of the cohort’s mean
health-related quality of life (HRQL) and its life
expectancy. The impact of childhood pedes-
trian injury and death on victim’s HRQL was
assessed using the EQ5D-5L,19 which was
distributed to 2 senior pediatric orthopedic
surgeons at Columbia University Medical
Center in New York City; they have extensive
experience working with adults who were
struck by motor vehicles as children. These
senior physicians were asked to provide sub-
jective assessments of the impact of the “aver-
age” child hospitalized for vehicular injury with
respect to that individual’s lifelong mobility,
self-care, usual activities, pain/discomfort, and
anxiety/depression.
The 2 EQ5D-5L instruments yielded scores
of 0.64 and 0.47, for an average value of 0.55
for injury victims who required hospitalization
(a value of 0 is equated with death, and a value of
1 indicates a year lived in perfect health). Based
upon this score for hospitalized school-aged pe-
destrians and a value of 1.0 for nonhospitalized
victims, we computed a weighted average HRQL
score of 0.95 for all individuals injured in crashes.
Probabilities
Additional inputs into the first model in-
cluded pedestrian-injury incidence rates and
pedestrian injury case fatality rates for both
SRTS and no SRTS arms. Model inputs are
listed in Table 1.4,5,12,17 We did not include
TABLE 1—Values Used in the Markov Model Evaluating Safe Routes to School (SRTS)
in New York City vs the Status Quo
Variable Base High Low
Injury risks
Increase in active transport, SRTS, % 10 12 8
Total pedestrians at risk, no.
School-aged children (5-19 y) 40 525 . . . . . .
Adults using intersection 181 148 . . . . . .
Annual probability of pedestrian injury, SRTS intersection
School-aged children (5-19 y) 0.0008 0.023 0.0004
Adults using intersection 0.002 0.014 0.0003
Risk ratio, injury, SRTS intersection
School-aged children (5-19 y) 0.67 0.83 0.35
Adults using intersection 0.86 0.88 0.84
Probability of hospitalization 0.12 0.16 0.08
Case fatality ratio 0.001 0.006 0.0007
Health-related quality of life,a injured 0.95 1 0.9
Cost inputs
Total program cost (NYC), $ 10 298 000 . . . . . .
Per capita program cost (NYC), $
School-aged children (5-19 y) 254 . . . . . .
Adults using intersection 57 . . . . . .
Injury cost, $
Hospitalized 50 832 60 998 40 666
Not hospitalized 1170 1404 936
Totalb 7129 11 139 4114
Death cost, $
Project year 1 6351 7621 5081
At end of life/school-aged children 930 1116 744
3 y of bus transit cost, $ 2016 . . . . . .
Mean user age
School-aged children, y 10 . . . . . .
Adults using intersection, y 35 . . . . . .
Note. NYC = New York City.
aThe health-related quality of life score is scaled 0 to 1, with 1 representing perfect health.
bDoes not include lost productivity and leisure time, which is assumed to be captured in the health-related quality of life
score.
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estimates of those injured who did not seek
medical care. It was conservatively estimated that
any given school-aged child (aged 5---19 years)
would only use an SRTS intersection for 3 years
before moving to another school or graduating.
Sensitivity Analyses
Before running sensitivity analyses, we found
that SRTS was cost saving even in the annual
cohort model. This model is relevant in the
event that all of the observed benefits of SRTS
are transient (e.g., if they all occurred through
the education component). Clearly, multiplying
these benefits by many years will only amplify
savings. Therefore, we only conducted sensi-
tivity analyses on the annual model. We con-
duced a series of one-way sensitivity analyses
along with a Monte Carlo simulation. In the
Monte Carlo simulation, we either included
what we recognized as plausible boundaries for
the values or we included the known random
error associated with an estimate. For example,
injury risk reductions were varied by the
standard errors. The amount of time a child
spends at a school, on the other hand, must be
bounded by guesswork because we do not
have adequate data on this for our SRTS
neighborhoods.
RESULTS
The model inputs are listed in Table 1, and
the underlying assumptions of the modeling
approach are listed in Table 2. For the first
cohort of intersection users, school-aged SRTS
users produce a net societal savings of $224
and an incremental gain of 0.0004 QALYs
over their lifetimes (Table 3). For all pedestrians
(societal costs), the figures are similar, with
$226 in savings and 0.0008 QALYs gained.
This single cohort analysis was robust to all
sensitivity analyses using a willingness-to-pay
threshold of $100 000 per life year gained
(a predetermined threshold for the purposes of
our sensitivity analyses only). An influence anal-
ysis (“tornado” diagram) suggests that the most
important variables in the analysis were the
probability of injury, transportation costs, the risk
reduction associated with SRTS, and the discount
rate. The impact on the incremental costs and
effectiveness of the model of variations in these
variables can be found in Table 4. These figures
reflect the returns that might be expected over
a single cohort of intersection users.
These single cohort costs, however, do not
reflect the likely true cost-effectiveness of SRTS
because intersection modifications tend to last
for decades, and most benefits are probably
realized through such modifications. When dis-
counted over the assumed 50-year useful life of
an intersection at a 3% rate, SRTS saves $5500
per user and results in a net effectiveness gain
of nearly 0.02 QALYs per user. In the parlance of
TABLE 2—Assumptions Used in the Markov Model Evaluating Safe Routes to School (SRTS) in New York City vs the Status Quo
Assumption Rationale (Impact on Estimates)
Future lost productivity and leisure time costs of injury are included within the
health-related quality of life score.
EQ5D scores may implicitly include lost productivity and leisure time, however this has been
debated.14 (Favors status quo.)
SRTS benefits were limited to roadway changes. Conventional wisdom holds that safety education programs are less important than roadway
modifications. (Favors SRTS.)
We assumed that exercise, reduced pollution, and reduced noise associated with
active transport to school would have no impact on future costs.
If active transport does produce lifelong health benefits, this assumption favors status quo.
Mortality risk occurs only at the time of injury. Injury victims may be at higher risk of future death both from physical limitations and the
economic impact of the injury on the victim’s life. (Favors status quo.)
TABLE 3—Costs and Quality-Adjusted Life Expectancy (QALE) of Safe Routes to School (SRTS) in New York City vs the Status Quo
School-Aged Pedestrians All Pedestrians
Variable Cost, $ Incremental Cost, $ QALE Incremental QALY Cost, $ Incremental Cost, $ QALE Incremental QALY
Per user per y
SRTS 4 –224 28.3009 0.0004 16 –226 51.7602 0.0008
Status quo 227 28.3005 242 51.7595
Per user older than 50 y
SRTS 352 –5449 721.7209 0.0103 664 –5500 1319.9715 0.0193
Status quo 5801 721.7106 6164 1319.9522
Total, NYCa
SRTS 14 246 784 –220 826 117 29 247 740 417 70 891 435 –230 047 354 137 619 641 2055
Status quo 235 072 901 29 247 323 300 938 789 137 617 585
Note. NYC = New York City; QALY = quality-adjuste life years.
aTotals tend to be much higher for all users only because many more adults tend to use these intersections than do school-aged pedestrians.
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cost-effectiveness analysis, SRTS is said to “dom-
inate” a no investment strategy (the status quo),
indicating that every dollar spent in SRTS saves
both money and lives. This dominance is not
impacted by variance in the plausible ranges of
the variables represented in Table 1, including
the overall Monte Carlo simulation, which pre-
dicts that SRTS would save money and lives in
virtually 100% of the simulations. The figures
represent savings per user. When all users of
SRTS intersections over 50 years are considered,
the overall discounted cost and effectiveness of
the policy is more apparent, reaching $230
million saved and 2055 QALYs gained.
When restricted to school-aged pedestrians,
the overall program cost remains the same
($10 million), but the number of users drops
substantially (from 181000 to 41 000). How-
ever, these drops are offset by a much longer
time horizon for which QALYs are gained (from
age 10 years rather than from age 35 years), by
reductions in bussing costs (which are a major
component of the model) and by a much larger
protection associated with SRTS (a risk reduction
of 33% rather than just a 14% average risk
reduction). The net result of targeting children
produces cost reductions of $221 million.
However, because adult users are much more
likely to be injured on average (possibly because
drivers are more careful during school hours and
crossing guards are present), most QALYs are
gained among adult users of SRTS intersections.
DISCUSSION
Whether evaluated using difference in dif-
ference or Bayesian changepoint analysis, SRTS
has been shown to reduce both childhood and
overall injury rates in New York City. Taken
together, these 2 methodological approaches
produce reasonable confidence that the observed
effects are not confounded by exogenous vari-
ables. To the extent that these results are valid,
SRTS appears to not only improve health and
save lives, but to also save money. Government
agencies that chose to invest in SRTS may
therefore receive returns on their investment
not only with respect to money but also with
respect to the health of their constituents. SRTS
is, by its nature, a program targeted toward
school-aged pedestrians rather than all inter-
section users. But even when the analysis is
limited to the benefits realized by children
(the policy target), the program remains
cost saving. When all users are considered
(the societal benefits), the cost-effectiveness
improves further.
It should be noted, though, that school zones
are likely already safer than other areas of
most cities. For example, speed limits are much
lower in school zones, and crossing guards
are often present during school hours. Much
greater benefits may be realized by improve-
ments to high-risk intersections outside of
school zones, including larger reductions in
childhood fatalities.
With respect to other benefits, SRTS appears
to increase the number of children who bike
or walk (relative to driving) to school.9,10,12,20
Obesity rates in New York City are dropping
simultaneously as street modifications are im-
plemented. However, although strongly sug-
gestive, there is no conclusive evidence that
active transport reduces the incidence of child-
hood overweight or obesity.21,22 The incidence
of childhood overweight and obesity is about
34% to 43% in New York City school-aged
children.23--25 The annual medical cost of child-
hood obesity is $220 per case among school-aged
children.26 However, about one third of obese
children become obese adults, and obese adults
accrue many additional costs, such as lost
productivity costs, and obesity accounts for
upwards of 10% of all medical costs.27,28 More-
over, the rise in obesity expenditures outstrips
the medical portion of the consumer price index
in part because obesity rates are increasing
and in part because, as the population ages,
the obese incur disproportionate costs.29
Were SRTS to prevent a small number of
cases of obesity in each cohort, this benefit
alone would likely pay for the entire program
over time.
This study was prone to a number of impor-
tant limitations. First, although upwards of
90% of SRTS funds were used for engineering
and infrastructure projects (e.g., sidewalk con-
struction),11 SRTS funded some education pro-
grams as well as roadway improvements. We
assumed that the effects of SRTS would be
limited primarily to roadway improvements
and therefore modeled these benefits over
50 years. Education benefits, however, tend
to be more transient. If the benefits of SRTS
were limited to education campaigns rather
than roadway improvements, then the ex-
pected benefits we observed would therefore
be greatly reduced. On the other hand, the
cost estimate that we used included both
infrastructure programs and roadway im-
provements. Therefore, if roadway improve-
ments are much more effective than education
campaigns, we would have underestimated
the cost-effectiveness of SRTS. Even when
analyzed over just 1 cohort, however, SRTS
produces a reasonable cost-effectiveness
estimate.
Another limitation is that our estimates ex-
clude any social or health benefits associated
with increased exercise, reduced neighborhood
traffic congestion, reduced pollution, and
perhaps increased neighborhood cohesion,
all of which may reduce excess morbidity and
mortality and improve quality of life in New
York City.30 These data are difficult to ascer-
tain, however. Inclusion of such costs could
further increase the value of SRTS. A final
important limitation is that our data were
not derived from multicenter randomized
TABLE 4—One-Way Sensitivity Analyses of Variables Included in the Annual Model
Incremental Cost Incremental Effectivenessa
Variable High Low High Low
Probability of injury –222 –223 0.0003 0.00005
Bussing costs –1366 –2651 . . .b . . .b
Risk reduction –223 –227 0.0008 0.00002
HRQL . . .b . . .b 0.0008 0
Discount rate –223 –224 0.001 0.0003
Note. HRQL = health-related quality of life. Variables are based on those used in the Markov model evaluating safe routes to
school.
aIncremental effectiveness was determined by quality-adjusted life years gained.
bChanges in the variable had no impact on this outcome measure.
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controlled trials. The estimates upon which we
base the effectiveness of SRTS are therefore
susceptible to unforeseen threats to internal
validity.
Finally, given its overall benefits, it would
be logical to expand the program to high-risk
intersections that fall outside of school zones.
However, doing so assumes that the results
of the present study are generalizable to high-
risk census tracts outside of those studied
here. Given that some questions remain sur-
rounding the internal validity and generaliz-
ability of SRTS, randomized implementation
of SRTS across neighborhoods in the United
States would simultaneously allow for invest-
ments in a program with social benefits and
conclusively demonstrate whether these benefits
are tenable.
Public health practitioners have moved be-
yond initiatives that require actions on the part
of the public, such as health education cam-
paigns, and on to innovative approaches to
improve population health.31,32 These include
initiatives that reengineer the environments of
the public such that they produce health.33---35
Such initiatives remove the requirement for
action on the part of the user, either protecting
the user from harm or “nudging” him or her
into safer behaviors. A particular approach has
entailed roadway modifications that make ac-
tive transport safer, simultaneously reducing
injuries and thereby reducing barriers to walk-
ing outside.9,10 In New York City, SRTS appears
a good investment from both the standpoint
of the policy’s intended target (school-aged
children) and overall (from a societal perspec-
tive). A large, nationally representative trail of
roadway modifications would greatly improve
our understanding of the overall utility and
cost-effectiveness of such investments. Such
a study would be especially timely given that
this cost-saving program has recently been
defunded. j
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